The objective of our trial was to evaluate the significance and useful
ness of sentinel lymphadenectomy (SLNE) for the staging of regional ly
mph nodes in breast cancer patients. The study presented illustrates t
he method and our results. As has been documentated for melanoma, the
first lymph node [sentinel node (SLN)] to receive lymphatic drainage f
rom a primary tumor is the expected first site of lymph-node metastasi
s. The database presented includes 12 patients with operable breast ca
ncer and clinically negative lymph nodes. In 11 cases the described me
thod was applicable. In only one case was there no correlation between
the histology of the SLN and the axillary specimen. Three SLN were tu
mor-positive. Successful completion of examination of a large number o
f patients with a long follow-up has the potential of reducing the num
ber of axillary dissections and of significantly reducing morbidity in
the majority of breast cancer patients.